Avoiding counterfeit injector pens

Counterfeit injector pens — particularly for tirzepatide and semaglutide — have become one of the most documented medicines-safety problems in modern UK healthcare. The MHRA issued multiple Drug Safety Updates between 2024 and 2025; the Counter Fraud Authority confirmed product seizures; and individual clinicians have published case reports of patients who received counterfeit material.

This is a practical, not theoretical, problem. The compounds work, the demand exceeds licensed supply, and the resulting grey market has been demonstrably hazardous.

What has been found in counterfeit pens

Documented findings from MHRA and CFA seizures include: pens containing insulin (life-threatening hypoglycaemia risk in non-diabetic users); pens containing only saline (no therapeutic effect, but injection-site infections); pens with incorrect doses (often higher than labelled, producing severe GI symptoms); and pens with legitimate appearance but fake batch numbers.

In several cases the counterfeit pens were sold via online pharmacies that initially appeared legitimate. Visual inspection of the pen itself is not a reliable safeguard.

How to buy safely

Three legitimate routes exist for licensed GLP-1 medicines in the UK: NHS prescription (eligibility-restricted via NICE criteria); private prescription via a GMC-registered prescriber and dispensed by a GPhC-registered pharmacy; or licensed-clinic supply through a regulated private weight-management service.

The two key markers of legitimacy are the prescriber registration (GMC for doctors, GPhC for pharmacists) and the pharmacy registration. Both registration numbers can be verified via public registers — gmc-uk.org for doctors, pharmacyregulation.org for pharmacies.

Red flags

Selling without a prescription, requiring no prescriber consultation, claiming "no prescription needed for personal-use quantities", offering substantially below-market pricing (legitimate Mounjaro starts around £170/month privately), shipping from outside the UK without a UK pharmacy involved, accepting cryptocurrency or gift-card payment only, and using messaging apps for orders rather than a regulated platform — any of these patterns should prompt extreme caution.

If you think you have a counterfeit

Stop using the product immediately. Report to the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk) and to your GP. If you've experienced symptoms — particularly hypoglycaemia, severe GI symptoms, or injection-site infection — seek medical advice.

The MHRA also encourages reporting of suspected counterfeit products even if you haven't used them. This contributes directly to enforcement against unregulated suppliers.